[go: up one dir, main page]

DE10312173A1 - Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac - Google Patents

Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac Download PDF

Info

Publication number
DE10312173A1
DE10312173A1 DE2003112173 DE10312173A DE10312173A1 DE 10312173 A1 DE10312173 A1 DE 10312173A1 DE 2003112173 DE2003112173 DE 2003112173 DE 10312173 A DE10312173 A DE 10312173A DE 10312173 A1 DE10312173 A1 DE 10312173A1
Authority
DE
Germany
Prior art keywords
chewing gum
stomach
pharynx
esophagus
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE2003112173
Other languages
German (de)
Inventor
Ingo Hornung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to DE2003112173 priority Critical patent/DE10312173A1/en
Publication of DE10312173A1 publication Critical patent/DE10312173A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The chewing gum is provided with active ingredients intended to produce a beneficial effect on the mouth cavity, pharynx, esophagus, stomach and digestive tract. An independent claim is also included for producing the proposed chewing gum. ACTIVITY : Gastrointestinal-Gen. No biological data is given. MECHANISM OF ACTION : None given.

Description

Mittel zur Behandlung von Erkrankungen des Mundraums, insbesondere des Zahnfleischs oder zur Vorbeugung solcher Erkrankungen werden nach dem Stand der Technik dort aufgetragen, wo sie wirken sollen. Das gilt grundsätzlich für den gesamten Rachenraum.Agents for the treatment of diseases of the mouth, especially the gums or for prevention such diseases are applied there according to the prior art, where they should work. This basically applies to the entire throat area.

Auch Mittel, die auf Magen oder Verdauungstrakt einwirken sollen, werden nach dem Stand der Technik eigens zu diesem Zweck eingenommen.Also means that on the stomach or digestive tract according to the state of the art Purpose.

Beides wird oft als Belästigung empfunden. Dem trägt die Erfindung damit Rechnung, dass die Mittel dem Kaugummi beigemengt und damit ohne weitere Belästigung dem Bestimmungszweck zugeführt werden.Both are often considered annoyances felt. That carries the invention so that the agent added to the chewing gum and thus without further annoyance the intended purpose become.

Claims (4)

Kaugummi, dem Wirkstoffe beigemengt sind, die auf Mundhöhle, Rachenraum, Speiseröhre, Magen, Verdauungstrakt einzuwirken bestimmt sind.Chewing gum, which contains active ingredients that on oral cavity, Pharynx, esophagus, Stomach, digestive tract are intended to act. Kaugummi nach Anspruch 1, dessen beigemengtes Mittel ein oder mehrere Vitamine enthält.Chewing gum according to claim 1, the admixed agent thereof contains one or more vitamins. Kaugummi nach Anspruch 1, dessen beigemengtes Mittel zur Vorbeugung oder Behandlung von Paradonthose bestimmt ist.Chewing gum according to claim 1, the admixed agent thereof is intended for the prevention or treatment of periodontal pants. Verfahren zur Herstellung von Kaugummi, dadurch gekennzeichnet, dass dem Kaugummi Mittel nach den Ansprüchen 1, 2 und 3 beigemengt werden.Process for the production of chewing gum, characterized in that that the chewing gum agent added according to claims 1, 2 and 3 become.
DE2003112173 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac Withdrawn DE10312173A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE2003112173 DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2003112173 DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Publications (1)

Publication Number Publication Date
DE10312173A1 true DE10312173A1 (en) 2004-09-30

Family

ID=32920959

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2003112173 Withdrawn DE10312173A1 (en) 2003-03-19 2003-03-19 Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac

Country Status (1)

Country Link
DE (1) DE10312173A1 (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685965T2 (en) * 1985-01-24 1992-12-24 Advance Kk ANTICARIOGENIC OR ANTIPERIODONTITIC AGENT.
DE69003244T2 (en) * 1989-07-24 1994-01-05 Fertin A S Vejle Chewing gum with accelerated administration of active agents.
DE19615820A1 (en) * 1996-04-06 1997-10-09 Holger Specht Dental care products containing orally absorbable components
DE19802050A1 (en) * 1998-01-21 1999-07-22 Labtec Gmbh Peridontal treatment composition providing local oral release of coenzyme Q10
DE69228922T2 (en) * 1991-12-20 1999-08-26 Block Drug Co Dentin desensitizer
DE19949575A1 (en) * 1999-10-14 2001-04-19 Michael Hermann Hinz Fluoride and flavonoid combination, e.g. in chewing gum and toothpaste, for the prevention of caries and the treatment of dental disorders
DE19941221A1 (en) * 1999-08-30 2001-08-16 Joachim Steuer Chewing gum contains - in the role of additives - hydrophilic vitamins and/or mineral substances and/or trace elements
DE69704426T2 (en) * 1996-05-03 2001-11-15 Atp Avant-Garde Technologies & Products S.A. Marketing & Licensing S.A., Vacallo METHOD FOR PRODUCING MEDICAL CHEWING GUM WITH A GOOD TASTE, INCLUDING AN INCLUDING COMPOUND
DE10065413A1 (en) * 2000-12-31 2002-12-12 Brecht Hans Michael Dentifrice

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3685965T2 (en) * 1985-01-24 1992-12-24 Advance Kk ANTICARIOGENIC OR ANTIPERIODONTITIC AGENT.
DE69003244T2 (en) * 1989-07-24 1994-01-05 Fertin A S Vejle Chewing gum with accelerated administration of active agents.
DE69228922T2 (en) * 1991-12-20 1999-08-26 Block Drug Co Dentin desensitizer
DE19615820A1 (en) * 1996-04-06 1997-10-09 Holger Specht Dental care products containing orally absorbable components
DE69704426T2 (en) * 1996-05-03 2001-11-15 Atp Avant-Garde Technologies & Products S.A. Marketing & Licensing S.A., Vacallo METHOD FOR PRODUCING MEDICAL CHEWING GUM WITH A GOOD TASTE, INCLUDING AN INCLUDING COMPOUND
DE19802050A1 (en) * 1998-01-21 1999-07-22 Labtec Gmbh Peridontal treatment composition providing local oral release of coenzyme Q10
DE19941221A1 (en) * 1999-08-30 2001-08-16 Joachim Steuer Chewing gum contains - in the role of additives - hydrophilic vitamins and/or mineral substances and/or trace elements
DE19949575A1 (en) * 1999-10-14 2001-04-19 Michael Hermann Hinz Fluoride and flavonoid combination, e.g. in chewing gum and toothpaste, for the prevention of caries and the treatment of dental disorders
DE10065413A1 (en) * 2000-12-31 2002-12-12 Brecht Hans Michael Dentifrice

Similar Documents

Publication Publication Date Title
Ramberg et al. The influence of gingival inflammation on de novo plaque formation
US20230165706A1 (en) Method and System to Reduce the Likelihood of Dental Caries and Halitosis
US20060018843A1 (en) Halitosis, gingivitis, and periodontitis treatment and preventative composition
WO2002078644A3 (en) Use of ozone for the treatment of dental and oral conditions
UA76696C2 (en) Combination of lactic acid bacteria and its use for prevention and treatment of infections and inflammatory conditions
CA2431565A1 (en) Pharmaceutical compositions based on anticholinergics and ciclesonide
Pretty et al. Associated postmortem dental findings as an aid to personal identification
ATE249828T1 (en) USE OF ISATIN AND OXINDOL DERIVATIVES FOR THE PRODUCTION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF MYCOBACTERIAL DISEASES
Lundqvist et al. Speech in connection with maxillary fixed prostheses on osseointegrated implants: a three‐year follow‐up study
EP1393734A4 (en) Drugs for intestinal diseases
Ray Orofacial myofunctional therapy in dysarthria: a study on speech intelligibility
DE10312173A1 (en) Chewing gum is provided with active ingredients intended to produce beneficial effects on the mouth cavity, pharynx, esophagus, stomach and digestive trac
Palmer et al. Nutrition and the oral health of the elderly
Wick Oral health in the long-term care facility
Bhalla et al. CO-ENZYME Q10:-ANOTHER ARMOUR FOR NOVEL PERIODONTAL THERAPY.
RU2139730C1 (en) Agent for treatment of mouth mucosa cavity and gingivae illnesses
JP2002114677A (en) Method for treating or preventing tooth and gingiva and preventing tool
Benítez et al. Medical Gingival Hyperplasia and Recurrent Aphthous Stomatitis in Epileptic Patient Inform of case
Handoo et al. Knowledge and Association of Nutrition and Diet Counselling Associated with Periodontal Diseases–A Questionnaire Based Survey
Hyatt Hygiene of the Mouth and Teeth
Roohan Enhancing Patient Outcomes Through Holistic and Integrative Dental Care
DENTAL 8th
White The Mouth and the teeth
DE69427927D1 (en) Use of trimetazidine in the manufacture of medicaments for the treatment of health disorders caused by the nephrotoxicity of cyclosporin A.
Kelsch Meth Mouth & Dental Care Considerations.

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8139 Disposal/non-payment of the annual fee